265 related articles for article (PubMed ID: 33204396)
1. Cellular Mechanisms Triggered by the Cotreatment of Resveratrol and Doxorubicin in Breast Cancer: A Translational In Vitro-In Silico Model.
Vargas JE; Puga R; Lenz G; Trindade C; Filippi-Chiela E
Oxid Med Cell Longev; 2020; 2020():5432651. PubMed ID: 33204396
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
[TBL] [Abstract][Full Text] [Related]
3. Ovatodiolide sensitizes aggressive breast cancer cells to doxorubicin, eliminates their cancer stem cell-like phenotype, and reduces doxorubicin-associated toxicity.
Bamodu OA; Huang WC; Tzeng DT; Wu A; Wang LS; Yeh CT; Chao TY
Cancer Lett; 2015 Aug; 364(2):125-34. PubMed ID: 25976769
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional microenvironment confers enhanced sensitivity to doxorubicin by reducing p53-dependent induction of autophagy.
Gomes LR; Vessoni AT; Menck CF
Oncogene; 2015 Oct; 34(42):5329-40. PubMed ID: 25619836
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine potentiates anti-tumor effect of resveratrol on pancreatic cancer via down-regulation of VEGF-B.
Yang Y; Tian W; Yang L; Zhang Q; Zhu M; Liu Y; Li J; Yang L; Liu J; Shen Y; Qi Z
J Cancer Res Clin Oncol; 2021 Jan; 147(1):93-103. PubMed ID: 32897433
[TBL] [Abstract][Full Text] [Related]
6. Effects of doxorubicin associated with amniotic membrane stem cells in the treatment of canine inflammatory breast carcinoma (IPC-366) cells.
Borghesi J; Caceres S; Mario LC; Alonso-Diez A; Silveira Rabelo AC; Illera MJ; Silvan G; Miglino MA; Favaron PO; Carreira ACO; Illera JC
BMC Vet Res; 2020 Sep; 16(1):353. PubMed ID: 32972410
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancer.
Anders CK; Adamo B; Karginova O; Deal AM; Rawal S; Darr D; Schorzman A; Santos C; Bash R; Kafri T; Carey L; Miller CR; Perou CM; Sharpless N; Zamboni WC
PLoS One; 2013; 8(5):e61359. PubMed ID: 23650496
[TBL] [Abstract][Full Text] [Related]
8. PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis.
Muñoz-Gámez JA; Martín-Oliva D; Aguilar-Quesada R; Cañuelo A; Nuñez MI; Valenzuela MT; Ruiz de Almodóvar JM; De Murcia G; Oliver FJ
Biochem J; 2005 Feb; 386(Pt 1):119-25. PubMed ID: 15456408
[TBL] [Abstract][Full Text] [Related]
9. Blockage of cytosolic phospholipase A2 alpha sensitizes aggressive breast cancer to doxorubicin through suppressing ERK and mTOR kinases.
Li Z; Qu M; Sun Y; Wan H; Chai F; Liu L; Zhang P
Biochem Biophys Res Commun; 2018 Jan; 496(1):153-158. PubMed ID: 29307829
[TBL] [Abstract][Full Text] [Related]
10. The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell lines.
Ilisso CP; Castellano M; Zappavigna S; Lombardi A; Vitale G; Dicitore A; Cacciapuoti G; Caraglia M; Porcelli M
Endocrine; 2015 Sep; 50(1):212-22. PubMed ID: 25577236
[TBL] [Abstract][Full Text] [Related]
11. [Zinc-modified Nanotransporter for Target Drug Therapy of Breast Cancer].
Skaličková S; Gargulák M; Löffelmann M; Ruttkay-Nedecký B; Kepinská M; Parák T; Kizek R
Klin Onkol; 2017; 30(Supplementum1):174-176. PubMed ID: 28471199
[TBL] [Abstract][Full Text] [Related]
12. Bafilomycin A1 triggers proliferative potential of senescent cancer cells in vitro and in NOD/SCID mice.
Was H; Barszcz K; Czarnecka J; Kowalczyk A; Bernas T; Uzarowska E; Koza P; Klejman A; Piwocka K; Kaminska B; Sikora E
Oncotarget; 2017 Feb; 8(6):9303-9322. PubMed ID: 28030837
[TBL] [Abstract][Full Text] [Related]
13. α-TEA cooperates with chemotherapeutic agents to induce apoptosis of p53 mutant, triple-negative human breast cancer cells via activating p73.
Tiwary R; Yu W; Sanders BG; Kline K
Breast Cancer Res; 2011 Jan; 13(1):R1. PubMed ID: 21214929
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial-mesenchymal transition and modulating SIRT1/β-catenin signaling pathway in breast cancer.
Jin X; Wei Y; Liu Y; Lu X; Ding F; Wang J; Yang S
Cancer Med; 2019 Mar; 8(3):1246-1257. PubMed ID: 30697969
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin and resveratrol induce apoptosis and autophagy following oxidative stress in malignant mesothelioma cells.
Lee YJ; Lee GJ; Yi SS; Heo SH; Park CR; Nam HS; Cho MK; Lee SH
Food Chem Toxicol; 2016 Nov; 97():96-107. PubMed ID: 27591926
[TBL] [Abstract][Full Text] [Related]
16. Anti-oxidant effect of bergamot polyphenolic fraction counteracts doxorubicin-induced cardiomyopathy: Role of autophagy and c-kit
Carresi C; Musolino V; Gliozzi M; Maiuolo J; Mollace R; Nucera S; Maretta A; Sergi D; Muscoli S; Gratteri S; Palma E; Bosco F; Giancotta C; Muscoli C; Marino F; Aquila I; Torella D; Romeo F; Mollace V
J Mol Cell Cardiol; 2018 Jun; 119():10-18. PubMed ID: 29654879
[TBL] [Abstract][Full Text] [Related]
17. ATP2A3 gene as an important player for resveratrol anticancer activity in breast cancer cells.
Izquierdo-Torres E; Rodríguez G; Meneses-Morales I; Zarain-Herzberg A
Mol Carcinog; 2017 Jul; 56(7):1703-1711. PubMed ID: 28150875
[TBL] [Abstract][Full Text] [Related]
18. SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells.
De Angelis A; Piegari E; Cappetta D; Russo R; Esposito G; Ciuffreda LP; Ferraiolo FA; Frati C; Fagnoni F; Berrino L; Quaini F; Rossi F; Urbanek K
Int J Cardiol; 2015; 189():30-44. PubMed ID: 25889431
[TBL] [Abstract][Full Text] [Related]
19. Effects of doxorubicin cancer therapy on autophagy and the ubiquitin-proteasome system in long-term cultured adult rat cardiomyocytes.
Dimitrakis P; Romay-Ogando MI; Timolati F; Suter TM; Zuppinger C
Cell Tissue Res; 2012 Nov; 350(2):361-72. PubMed ID: 22864983
[TBL] [Abstract][Full Text] [Related]
20. Chlorogenic Acid Enhances Doxorubicin-Mediated Cytotoxic Effect in Osteosarcoma Cells.
Salzillo A; Ragone A; Spina A; Naviglio S; Sapio L
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
